MedTech Patent Litigation

Our patent litigation attorneys have handled dozens of cases having market impact in the tens or hundreds of millions of dollars. Significant achievements in patent litigation include plaintiffs' verdicts of $129 million and $57 million, a defense verdict of $0 on an $85 million claim, and dismissal of a seven figure breach of license agreement following an arbitration hearing. We have negotiated many confidential settlements and licensing deals in the MedTech space, having a total value approaching $1 billion.

Technical areas in which our team members have worked include:

Vascular stents and stent grafts

PFO occluders

Spinal fixation devices

Surgical devices

Glucose meters

Insulin pumps

Synthetic orthopedic casting tapes

Glaucoma treatments

Dialysis machines

Catheters

Nutrition formulas

We understand this competitive industry, and the ways to effectively represent you in patent infringement matters. We have significant experience in conducting trials, Markman hearings, summary judgment proceedings, IPR/PGR proceedings before the PTAB, and appeals to the Federal Circuit Court of Appeals. A number of our team members are registered patent attorneys with the Patent and Trademark Office, certification which requires both a law degree and a technical degree. We also offer an in-house e-discovery department as a service to reduce costs for our clients. We make it our goal to effectively enforce or defend against patent infringement claims while providing high return on investment to our clients.

Representative Matters

Represented Fortune 100 manufacturing company in patent infringement dispute against competitor relating to synthetic orthopedic casting tapes. Obtained $129 million verdict in favor of client, which verdict was upheld on appeal.

IntellectualIP is a Briggs and Morgan and University of Minnesota Law School – Educational Co-Sponsor blog. It’s intended to provide practical information concerning U.S. and international intellectual property law. Opinions expressed on this blog do not reflect University of Minnesota support or endorsement of Briggs and Morgan or of any other non-university entity cited or linked to on this site.